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Abstract
Background: Pharmacogenomics studies the relationship between genetic variation and the
variation in drug response phenotypes. The field is rapidly gaining importance: it promises drugs
targeted to particular subpopulations based on genetic background. The pharmacogenomics
literature has expanded rapidly, but is dispersed in many journals. It is challenging, therefore, to
identify important associations between drugs and molecular entities – particularly genes and
gene variants, and thus these critical connections are often lost. Text mining techniques can
allow us to convert the free-style text to a computable, searchable format in which
pharmacogenomic concepts (such as genes, drugs, polymorphisms, and diseases) are identified,
and important links between these concepts are recorded. Availability of full text articles as input
into text mining engines is key, as literature abstracts often do not contain sufficient information
to identify these pharmacogenomic associations.
Results: Thus, building on a tool called Textpresso, we have created the Pharmspresso tool to
assist in identifying important pharmacogenomic facts in full text articles. Pharmspresso parses
text to find references to human genes, polymorphisms, drugs and diseases and their
relationships. It presents these as a series of marked-up text fragments, in which key concepts
are visually highlighted. To evaluate Pharmspresso, we used a gold standard of 45 human-curated
articles. Pharmspresso identified 78%, 61%, and 74% of target gene, polymorphism, and drug
concepts, respectively.
Conclusion: Pharmspresso is a text analysis tool that extracts pharmacogenomic concepts
from the literature automatically and thus captures our current understanding of gene-drug
interactions in a computable form. We have made Pharmspresso available at http://
pharmspresso.stanford.edu.
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Background
To catalyze progress in understanding the molecular basis
of drug response and its variability in humans, pharma-
cogenomics researchers need to establish connections
between genes, gene polymorphisms, drugs, and diseases.
However, pharmacogenomics is a dynamic field with a
growing literature, and this wealth of published informa-
tion can be difficult to track because it is published in
many discipline-specific journals. To address this diffi-
culty, researchers sometimes perform multiple searches
repetitively – differing only in their syntax but not seman-
tics – to find facts that match certain patterns. For exam-
ple, a query template may be "{gene} VERB {drug}",
where the {gene} and {drug} are a specific gene and drug
of interest to the researcher, and the verb phrase is one of
the following three: 'binds', 'interacts with', or 'associates
with'. These searches are very similar, and yet must be per-
formed separately to extract all articles that contain each
of the particular triplets, as there is no existing method to
search using a category that includes the three verb
phrases. Text mining approaches may be useful in
addressing this problem, because computational tech-
niques can automatically scan, retrieve and summarize
the literature and store it in a computable format. Search
techniques such as PubMed and Google are keyword-
based, and do not contain semantic information about
desired relationships in text. Natural language processing
has been applied to pharmacogenomics in the past [1,2],
but there is an opportunity now to use it for extracting the
connections between the entities of interest in pharma-
cogenomics. Template-based semantic search can allow
these connections to be automatically extracted, building
on the commonalities in the sentence structure. The tem-
plates must be tailored to the specific field of research, in
order to incorporate the terms and categories of interest to
the researcher.
Separate from the technical issues of information extrac-
tion is the choice of text corpus. A major limitation of
many search methods is that only literature abstracts are
indexed. However, the full text of the articles may offer
improved performance.
Some systems can support semantic concept-based search
or relationship extraction, including Relemed [3], iHOP
[4], Ingenuity Pathways [5], GENIES [6], CBioC [7], and
GeneWays [8], but these systems do not generally provide
search within full text and visual mark-up of the search
results within the local context.
The Textpresso search engine is a template-based text
search engine developed for Model Organism databases
[9]. Textpresso uses an expert-built ontology that contains
categories of phrases and words of biological interest.
Database curators and users specify particular types of
objects and relationships of interest, and the system finds
articles that match these. Textpresso is based on a large set
of regular expressions written to find templated relation-
Table 1: Pharmspresso ontology examples.
CATEGORY TYPE
Biological entity Example words/phrases
Cell or cell group germ line cells, intenstines, sensory neurons
Cellular component* axons, integrins, mitochondrial membrane
Disease stroke, chronic leukemia, tuberculoma
Drug acebutolol, mechlorethamine, tartaric acid
Gene ABCB1, CYP2C9, coagulation factor V
Organism mice, rat, xenopus laevis
Polymorphism T168N, 1039G-A, 236Arg->Lys
Relationships between entities Example words/phrases
Action assists, acomplishes, recognizes
Association associates, binds, interacts
Biological Process* acetylated, matures, reactivations
Characterization has, contains, displays, includes, lacks
Comparison correlates, differs, equally, matches
Effect accumulates, aggregates, causes
Examples of Textpresso biological entities and relationships, along with additions for Pharmspresso (in bold). The ontology includes 35 categories 
of two types: (1) biological entities and (2) relationships between entities. Category names and examples of these categories are shown. * marks 
categories imported from Gene Ontology (GO).BMC Bioinformatics 2009, 10(Suppl 2):S6 http://www.biomedcentral.com/1471-2105/10/S2/S6
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ships in text. It indexes the full text of articles that are pro-
vided as PDF files. Constraints can be added to queries –
for example, specifying that two entities appear in the
same sentence in the article. Highlighted search results
allow the searcher to efficiently skim search results.
We hypothesized that with minor modifications Text-
presso would be useful for the task of identifying and
extracting pharmacogenomic relationships. In particular,
we wanted to extend Textpresso to be useful for pharma-
cogenomics literature focusing on drugs, human genes,
their variants, and the associated molecular and cellular
phenotypes. Articles processed by our modified Text-
presso (Pharmspresso) are selected to be relevant to phar-
macogenomics based on previously reported tools [1,10].
Table 1 shows examples of categories and terms identified
by Pharmspresso. We evaluated our extension by compar-
ing the ability of Pharmspresso to extract information
about genes, drugs and polymorphisms from 45 articles,
to the performance of 11 human gold standard evaluators
reading the same literature.
Results
Pharmspresso overview
Table 2 gives an overview of the Pharmspresso database.
The current corpus contains 1025 full text articles from
343 different journals. Future releases of Pharmspresso
will incorporate larger numbers of articles, as well as
abstracts in cases where full text was not available.
Figure 1 shows the Pharmspresso pipeline for document
retrieval and information extraction. We were able to sig-
nificantly improve runtime of the markup algorithm,
which can now mark up 1000 articles in less than 5 min-
utes on a single core consumer grade PC.
Pharmspresso can extract facts relevant to a specific gene
Figure 2 shows a snapshot of the Pharmspresso search
page. It shows a typical scenario in which users want arti-
cles establishing a relationship between a drug and a gene
variant. Users can specify keywords and categories from
the ontology that should appear within the same sentence
in an article. The search results show all articles fitting
these criteria, as shown in Figure 3. In the displayed query,
the user searched for all articles that mention ABCB1
(which is a gene), along with any term from the drug cat-
egory and a polymorphism. The snapshot shows that the
corpus contains 8 articles that contain such a sentence,
with a total of 20 such sentences.
Figure 4 shows the specific sentences found by the search
engine, color-coded based on the query, allowing swift
perusal of search results. Several sentences that matched
the query are displayed; the first hit is the only one that is
part of an abstract, and would thus be available on
PubMed.
Pharmspresso can extract categorical facts and 
relationships between categories of biological entities
In other queries, particular relationships of interest can be
specified in addition to keywords. For example, a user
may require a relationship synonymous with "associa-
tion" or "effect" to be found within a sentence. In particu-
lar, patterns such as "{drug} {association} {gene}" can
be found by querying for sentences containing these three
categories. Specific instantiations of {gene}, such as
'CYP2C19', can be sought by querying for the keyword
'CYP2C19' with the categories {drug} and {association}.
For example, the article by Ha-Duong et al. titled 'Ticlopi-
dine as a selective mechanism-based inhibitor of human
cytochrome P450 2C19', includes the following sentence
retrieved by Pharmspresso: "Spectral interaction studies
demonstrate that ticlopidine readily binds to the protein
active site of CYP2C19" [11].
Pharmspresso finds information not present in abstracts 
alone
Figure 5 shows the result of a query that finds no relevant
sentences from the article abstract, but does find a sen-
tence in the full text. The importance of full text in infor-
mation extraction has been detailed in [9]. Figure 6 shows
another example of sentences found in the full text but
not in the abstract. The fact retrieved is a terse summary of
findings from a different article. In this case, the refer-
enced article is not in the Pharmspresso corpus, but the
summary in full text is nevertheless still retrieved.
Evaluation of Pharmspresso system
We performed an evaluation of the system by comparing
the information extraction by Pharmspresso to a gold
standard of manual curation (see Methods for details).
The 45 articles used in our evaluation contain 178 gene
mentions; Pharmspresso finds 78.1% (139) of these. The
gold standard contains 255 polymorphism mentions;
Pharmspresso finds 48.6% (124). When compared to the
non-table gold standard (see Methods for description of
this), Pharmspresso performance rises to 60.8% [124/
(255-51)], as there are 51 mentions that appear in tables
Table 2: Overview of the Pharmspresso database.
# articles 1,025
# journals 343
# gene terms recognized* 102,334
# drug terms recognized 3,756
# disease terms recognized** 36,843
* Includes names, symbols, aliases
** Includes redundancies in MeSH thesaurus
We used the MeSH thesaurus disease terms, including many 
synonyms and phrase permutations that create redundancy in disease 
matches. However, these are required to capture the different ways 
in which they appear in natural language.BMC Bioinformatics 2009, 10(Suppl 2):S6 http://www.biomedcentral.com/1471-2105/10/S2/S6
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embedded in the article as images. The gold standard con-
tains 191 drug mentions; Pharmspresso finds 74.4%
(142). If we query {gene} and {drug} together, Pharm-
spresso finds 50.3% of these associations. Table 3 con-
tains a summary of these results.
Discussion
Pharmspresso's main strengths are its ability to process
full text articles and index their contents based on an
ontology of key concepts, on a corpus of literature rele-
vant to the field of pharmacogenomics. It provides a
search engine for finding entities and semantic relation-
ships between them of pharmacogenomic importance.
Pharmspresso identifies relationships because it has a
model of the words used to associate different concepts.
Its display allows users quickly to browse through search
results.
Because Pharmspresso uses regular expressions that may
be imprecise, it can retrieve false positive search results.
For example, in one article (PMID 15564882) the ligand
'E1S' is tagged as a polymorphism, similar in pattern to
E216S which indicates a substitution at position 216 from
glutamic acid to serine. Fortunately, the highlighted
search results are easy to peruse, and irrelevant hits can
quickly be discarded by users. The parsing of author
names in the reference section of an article also leads to
false positive gene polymorphisms, and the bibliogra-
phies should probably be removed from the corpus.
Some instances are missed by regular expressions that are
too precise. For example, the gene name OCT-1 appears in
the literature, whereas our lexicon contains the more
standard notation OCT1 for this gene. Pharmspresso
misses OCT-1 as a gene. Careful refinement of gene name
templates could improve performance.
Pharmspresso pipeline for data processing Figure 1
Pharmspresso pipeline for data processing. The Pharmspresso pipeline for data processing: full text PDFs of articles are 
downloaded, converted to text, and tokenized into individual words and sentences. Next, the text is parsed to identify words 
or phrases that are members of specific categories within the ontology. These are marked as such and indexed for future 
search accessibility.
Pharmspresso search page Figure 2
Pharmspresso search page. Snapshot of Pharmspresso search page. User is searching for text that includes the keyword 
'ABCB1' as well as a member of the {drug} category and a member of the {polymorphism} category, within the abstract or full 
text.BMC Bioinformatics 2009, 10(Suppl 2):S6 http://www.biomedcentral.com/1471-2105/10/S2/S6
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The creators of the Textpresso ontology often included the
category name as a term in the category, such as the term
'cell' in the category 'cell or cell group'. This practice was
useful to us, in particular with the inclusion of the word
'gene' in the {gene} category. Pharmspresso can thus
highlight gene mentions, even if the gene itself does not
appear in our lexicon; we can identify genes because the
word 'gene' is highlighted. For example, in the sentence
from PMID 12123487: 'the individual response to gemfi-
brozil could be partly explained by polymorphisms in
genes coding for apolipoproteinB (apoB) and apoA1CIII',
the drug gemfibrozil is reported to be in a relationship
with the genes 'apolipoproteinB' and 'apoA1CIII', which
do not appear in the Pharmspresso drug lexicon. How-
ever, because the word 'genes' does appear in the lexicon,
this text snippet is highlighted, with the word 'genes' high-
lighted, and thus allows the researcher to examine the arti-
cle in which the sentence appears. This also allows us to
refine our gene lexicon to include the two genes men-
tioned. Similarly, if we expand the polymorphism cate-
gory to identify the words 'polymorphism', 'variant', and
'allele', performance is likely to improve.
Our focus on the identification of polymorphism men-
tions in the literature, was in identifying those variants
that can be mapped to specific locations in the genome.
Thus, Pharmspresso does not recognize gene variant
names that follow the "star notation" (such as
'CYP2A6*4') as a polymorphism, as they do not give any
explicit genomic location information. However, Pharm-
spresso can easily be engineered to identify these variants,
perhaps using a new category in the ontology. For exam-
Pharmspresso results page Figure 3
Pharmspresso results page. Results page for the search shown in Figure 2. There are eight publications (from the corpus of 
1025 in Pharmspresso) that include a total of 20 sentences fulfilling the query conditions. Users may view the sentences in each 
of these articles that match the query. The number of matches indicates the number of sentences containing the query key-
words and categories.BMC Bioinformatics 2009, 10(Suppl 2):S6 http://www.biomedcentral.com/1471-2105/10/S2/S6
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ple, in the 45 articles reviewed by the evaluators, there
were 117 mentions of variants that follow the star nota-
tion. Pharmspresso uses a relatively simple algorithm for
finding polymorphisms. Others have reported more com-
plex methods – sometimes more domain-specific and
usually more computationally expensive for finding gene
and variant mentions [12-17]. These may be incorporated
in future versions of our system.
In our evaluation of polymorphism and gene detection,
one of the 45 articles contained a large table with all the
mentions of polymorphisms. However, as this table was
an image embedded in the article, the conversion from
PDF to text did not capture this information. This is a lim-
itation of the system. For the purposes of this analysis,
that article was removed and the analysis of polymor-
phism mentions included only 44 articles. We find that
the most important polymorphisms are often also men-
tioned in the text of the article itself, and thus are not
missed by Pharmspresso.
We note that there were some bona fide polymorphisms in
the literature that the annotators missed – these would
have raised performance in identification of polymor-
phism mentions.
Marked-up sentences found in corpus which match user query Figure 4
Marked-up sentences found in corpus which match user query. Sentences matching the query are color-coded with 
keywords and categories highlighted. In this example, 'tacrolimus' is a member of the {drug} category, and 'G2677T' and 
'C3435T' are members of the {polymorphism} category. Pharmspresso displays the title and sentence number within the text.
Pharmspresso retrieves sentences from full text not found when scanning abstract only Figure 5
Pharmspresso retrieves sentences from full text not found when scanning abstract only. User queried for 'warfa-
rin' keyword + a member of the {polymorphism} category. Results show that the article titled 'Relative impact of covariates in 
prescribing warfarin according to CYP2C9 genotype' contains such a sentence, but this sentence would not be found by read-
ing abstract only, as it is sentence number 132 in the article, which actually appears in the 'Discussion' section. Although the 
'star notation' (*2, *3) is used earlier in the article to describe gene variants, explicit genomic location information which can be 
used to map this polymorphism is first given in sentence 132.BMC Bioinformatics 2009, 10(Suppl 2):S6 http://www.biomedcentral.com/1471-2105/10/S2/S6
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Pharmspresso identifies 74.4% of drug mentions when
querying for the {drug} category, as opposed to only
50.3% if querying for {gene} and {drug} categories
together. Often, the gene is described in once sentence,
and the drug in the following sentence. Thus the strict
limit of one sentence only might best be relaxed to allow
2 or more sentences. Pharmspresso does not currently
have a mechanism to rank the most likely or most fre-
quently mentioned associations. Such a ranking could
assist users in deciding which associations are the most
reliable.
A bottleneck in the process of the Pharmspresso pipeline
is the gathering of the full-text articles. It can be tedious to
download PDFs from journals that publish work on Phar-
macogenomics. We anticipate that the improved availa-
bility of full text may permit partnerships with publishers
to streamline the pipeline. Another limitation of the sys-
tem is that Pharmspresso only works on a pre-defined cor-
pus of relevant articles, and not on all existing literature.
In the future, Pharmspresso will include a larger corpus,
and abstracts will be used when the full text is not availa-
ble. Additionally, the results of the information extraction
will be downloadable in tabular format, useful for build-
ing interaction networks.
The Pharmspresso package is available to the public at
http://pharmspresso.stanford.edu.
Conclusion
Pharmspresso is a resource that extracts information from
full text articles by identifying key pharmacogenomic con-
cepts and the relationships between them. It marks up a
corpus of literature based on an ontology of concepts,
among which are the classes genes, gene variants, drugs,
and polymorphisms. Subsequently, it displays the sen-
tence-level results to the user as visually enhanced text,
highlighting the relevant extracted concepts within their
local context. Pharmspresso is easily extendible to other
disciplines. As the increasing amount of published litera-
ture makes it very difficult for humans to manage the
knowledge in a scientific field, automated tools are
needed to organize the information and effectively under-
stand unstructured text. We are working on making
Pharmspresso a robust system that will automatically
retrieve relevant literature, mark it up using our ontology,
extract the facts of interest, and use them to populate a
database of interactions. In addition to serving as a
resource for human users, the knowledge collected by
Pharmspresso may also be amenable to automated data
mining and relationship-discovery methods.
Methods
Pharmspresso ontology
We created the Pharmspresso ontology by adding to the
existing Textpresso ontology the human gene, drug, poly-
morphism and disease categories. The gene list uses
names, symbols and aliases described by the HUGO Gene
Nomenclature Committee (HGNC [18]), as well as addi-
tional gene names found in the literature and compiled by
the team of PharmGKB scientific curators. The drug list
was created by using the PharmGKB drug dictionary,
which includes drug lists compiled by Apelon Inc. and
Micromedex, as well as manual entries. Polymorphisms
are recognized by regular expressions written in the Perl
programming language, which include the common ways
in which polymorphisms are described in the literature
(e.g. A3435T, ARG23LYS, and variations), as well as rs and
ss numbers corresponding to dbSNP entries [19]. The dis-
Table 3: Pharmspresso performance in evaluation.
Entity Type % Recovered
Gene 78.1
Polymorphism 48.6
Polymorphism (non-table gold standard) 60.8
Drug 74.4
Summary of Pharmspresso performance in evaluation. The rows 
report percent of gene, gene-variant (polymorphism), and drug 
mentions found by the gold standard, recovered by Pharmspresso.
Pharmspresso retrieves fact from referenced article Figure 6
Pharmspresso retrieves fact from referenced article. User queried for both keywords 'CYP2D6' and 'codeine' and a 
member of the {polymorphism} category. Although the article ('Functional Analysis of Six Different Polymorphic CYP1B1 
Enzyme Variants Found in an Ethiopian Population') discusses the gene 'cytochrome P450 1B1' and not 2D6, there is a refer-
ence to knowledge in a referenced article, regarding a polymorphism in CYP2D6 (not in CYP1B1) and its affect on affinity for 
codeine. Thus, this article is extracted in response to the query.BMC Bioinformatics 2009, 10(Suppl 2):S6 http://www.biomedcentral.com/1471-2105/10/S2/S6
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ease category includes disease terms of the MeSH thesau-
rus, as well as additional disease names found in the
literature and compiled by the team of PharmGKB scien-
tific curators.
Pharmspresso implementation
We used the Textpresso open source package to build
Pharmspresso. A corpus of literature was downloaded
from the web, totaling 1025 full text articles in PDF for-
mat. We used a free software package, xpdf http://
www.foolabs.com/xpdf, to convert PDF files to text; Perl
scripts adapted from Textpresso were used to tokenize
sentences and words. We implemented a tagging algo-
rithm in Perl to tag text with the Pharmspresso ontology
in XML format, and subsequently index the tagged text for
use by the search engine.
CGI scripts access the database and create the HTML pages
shown to the user. Figure 1 shows the Pharmspresso pipe-
line. In step 4 of the pipeline, each article is parsed for
identification of all terms in the ontology that appear in
the text. This process takes less than five minutes per 1000
full text articles on a single core consumer grade PC. Steps
2, 3 and 5 take a total of several minutes of computational
time for the entire corpus.
We built a website for Pharmspresso, which allows search
of the current corpus of literature, and is available at http:/
/pharmspresso.stanford.edu.
Pharmspresso corpus
The corpus of literature included in the current build of
Pharmspresso (1025 downloaded full text PDFs) is papers
currently in the PharmGKB, which have been manually
verified as relevant to pharmacogenomics. We can also
identify relevant literature by automatic extraction using a
text classifier [1,20], by receiving submissions from the
user community, or via annotation by PharmGKB cura-
tors.
Evaluation
We evaluated Pharmspresso as follows: (1) We recruited
gold standard evaluators (scientists familiar with pharma-
cogenetics literature), and sent each five articles (selected
from the PharmGKB annotated corpus), with instructions
to find within the full text of the article all mentions of
genes, polymorphisms (with the associated gene name),
and drugs. (2) Eleven evaluators reviewed a total of 45
articles. (3) We measured (i) the percent of gold-standard
gene-mentions found by Pharmspresso when querying for
sentences containing a term from the {gene} category, (ii)
the percent of polymorphism mentions found by Pharm-
spresso when querying for sentences containing terms
from both the {polymorphism} and {gene} categories,
and (iii) the percent of drug mentions found by Pharm-
spresso when querying for sentences containing a term
from the {drug} category.
When evaluating the performance of Pharmspresso in
identification of polymorphism mentions, we compared
to two versions of the gold standard: (i) the strict gold
standard, which includes all mentions found by the eval-
uators, and (ii) a "no-table" gold standard, which removes
from consideration those mentions annotated by the eval-
uators, that appeared only in a table embedded in the PDF
as an image (and thus were not converted to text, thereby
impossible for Pharmspresso to detect).
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